手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按作者
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
359条
与
C.
有关的结果
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis
2022 年 发布于
Int J Nurs Pract
13 卷 第 4 期
Garcia-Rojo D.
Munoz-Rodriguez J.
Centeno
C.
Dominguez A.
Prera A.
Abad
C.
Vicente E.
Gonzalez-Sala J. L.
Hannaoui N.
Capdevila M.
De Verdonces L.
Ferran A.
Pla
C.
Azuara P.
Cuadrench S.
Zegri M. E.
Prats J.
非肌层浸润性膀胱癌
卡介苗
维持治疗
诱导治疗
文献简介
原文链接
The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review
2022 年 发布于
Eur Urol Focus
13 卷 第 5 期
Petzold A. P.
Lubianca F. N.
Passos L. G.
Keppler
C.
K.
Becker N. B.
Viera
C.
D.
Fay A. P.
Carvalhal G. F.
Bladder cancer
Hpv
Human papillomavirus
Meta-analysis
文献简介
原文链接
Low-dose versus standard-dose bacille Calmette-Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials
2022 年 发布于
Eur J Nutr
27 卷 第 11 期
Choi S. Y.
Ha M. S.
Kim J. H.
Chi B. H.
Kim J. W.
Chang I. H.
Kim T. H.
Myung S.
C.
androgen suppression therapy
bladder cancer
incidence
meta-analysis
recurrence
commercial or financial relationships that could be construed as a potential
conflict of interest.
文献简介
原文链接
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis
2022 年 发布于
Frontiers in Oncology
8 卷 第 17 期
Mori K.
Schuettfort V. M.
Yanagisawa T.
Katayama S.
Pradere B.
Laukhtina E.
Rajwa P.
Mostafaei H.
Sari Motlagh R.
Quhal F.
Moschini M.
Soria F.
Teoh J. Y.
C.
D'Andrea D.
Abufaraj M.
Albisinni S.
Krajewski W.
Egawa S.
Karakiewicz P. I.
Rink M.
Shariat S. F.
microbiota
systematic review
urinary bladder neoplasms
文献简介
原文链接
From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)
2022 年 发布于
Cancers (Basel)
44 卷 第 3 期
Deininger S.
Törzsök P.
Mitterberger M.
Pallauf M.
Oswald D.
Deininger
C.
Lusuardi L.
Bladder cancer
Intra-arterial chemotherapy
Intravesical chemotherapy
Recurrence
Survival
文献简介
原文链接
Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review
2022 年 发布于
Eur Urol Focus
28 卷 第 6 期
Yuen J. W.
Wu R. W.
Ching S. S.
Ng
C.
F.
Biomarkers/urine
Carcinogenesis
Carcinogens/toxicity
Female
Humans
Male
*Tobacco Products/adverse effects
*Urinary Bladder Neoplasms/etiology
Biomarkers of exposure
Bladder cancer
Carcinogens
Heated tobacco product
Urine
disclosures.
文献简介
原文链接
[Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review]
2022 年 发布于
Front Pharmacol
4 卷 第 1 期
Melzer M. K.
Zehe V.
Zengerling F.
Wezel F.
Günes
C.
Maisch P.
Bolenz
C.
Humans
*Urinary Bladder Neoplasms/surgery/pathology
Lasers
Urethra/surgery
Treatment Outcome
Length of Stay
2-micron laser
bladder cancer
meta-analysis
randomized controlled trials
trans-urethral resection of bladder tumor
文献简介
原文链接
Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma: Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis
2022 年 发布于
Eur Urol Focus
47 卷 第 1 期
Li H.
Ni M.
Xue
C.
Li L.
Huang R.
Yang W.
Hu A.
An X.
Shi Y.
Data Systems
Humans
Magnetic Resonance Imaging/methods
*Multiparametric Magnetic Resonance Imaging
Reproducibility of Results
Urinary Bladder/diagnostic imaging/pathology
*Urinary Bladder Neoplasms/diagnostic imaging/surgery
Bladder cancer
Bladder cancer staging
Multiparametric magnetic resonance imaging
Muscle-invasive bladder cancer
conflict of interest to disclose.
文献简介
原文链接
Neoadjuvant immunochemotherapy in the treatment of nonmetastatic muscle-invasive bladder cancer: a systematic review
2022 年 发布于
Cancer Treat Rev
8 卷 第 1 期
Sarkis J.
Vannier E.
Mjaess G.
Pochet
C.
Albisinni S.
Quackels T.
Roumeguere T.
Cystoscopy
Humans
Narrow Band Imaging/methods
Neoplasm Recurrence
Local
Randomized Controlled Trials as Topic
*Urinary Bladder Neoplasms/diagnostic imaging/drug therapy/surgery
文献简介
原文链接
Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis and Network Meta-Analysis with Focus on Different Energy Sources
2022 年 发布于
BJU Int
5 卷 第 5 期
Motlagh R. S.
Rajwa P.
Mori K.
Laukhtina E.
Aydh A.
Katayama S.
Yanagisawa T.
Koenig F.
Grossmann N.
C.
Pradere B.
Mostafai H.
Quhal F.
Karakiewicz P. I.
Babjuk M.
Shariat S. F.
Female
Humans
Male
Research Design/*standards
Urinary Bladder Neoplasms/*diagnosis/*diagnostic imaging
Bladder cancer
Magnetic resonance imaging
Meta-analysis
Vesical Imaging Reporting and Data System
文献简介
原文链接
P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer
2022 年 发布于
Medicine
50 卷 第 3 期
Zhang J.
Dong Y.
Shi Z.
He H.
Chen J.
Zhang S.
Wu W.
Zhang Q.
Han
C.
Hao L.
*Carcinoma
Transitional Cell
Humans
Prognosis
Retrospective Studies
*Urinary Bladder Neoplasms/surgery
*Urinary Tract
文献简介
原文链接
Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer
2022 年 发布于
Arch Ital Urol Androl
33 卷 第 2 期
Lai L. Y.
Tafuri S. M.
Ginier E.
C.
Herrel L. A.
Dahm P.
Maisch P.
Lane G. I.
Cisplatin/adverse effects
Humans
*Immunotherapy/adverse effects/methods
*Muscles/pathology
*Neoadjuvant Therapy/adverse effects
Neoplasm Staging
*Urinary Bladder Neoplasms/drug therapy/pathology/therapy
chemoimmunotherapy
immunotherapy
meta-analysis
muscle-invasive bladder cancer (MIBC)
neoadjuvant
commercial or financial relationships that could be construed as a potential
conflict of interest.
文献简介
原文链接
Safety and efficacy of en bloc vs. conventional transurethral resection of bladder tumors: a meta-analysis and systematic review
2022 年 发布于
Arch Ital Urol Androl
13 卷 第 12 期
Oswald D.
Pallauf P.
Deininger S.
Herrmann T. R. W.
Netsch
C.
Becker B.
Fiedler M.
Haecker A.
Homberg R.
Klein J. T.
Lehrich K.
Miernik A.
Olbert P.
Schob D. S.
Sievert K. D.
Gross A. J.
Westphal J.
Lusuardi L.
Humans
*Neoplasm Recurrence
Local/drug therapy
*Urinary Bladder Neoplasms/pathology
Infusions
Intra-Arterial
Chemotherapy
Adjuvant
Adverse Reactions
bladder cancer
intra-arterial chemotherapy
meta-analysis
prognosis
文献简介
原文链接
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021)
2022 年 发布于
Int Braz J Urol
40 卷 第 1 期
Laukhtina E.
Shim S. R.
Mori K.
D'Andrea D.
Soria F.
Rajwa P.
Mostafaei H.
Comperat E.
Cimadamore A.
Moschini M.
Teoh J. Y.
C.
Enikeev D.
Xylinas E.
Lotan Y.
Palou J.
Gontero P.
Babjuk M.
Witjes J. A.
Kamat A. M.
Roupret M.
Shariat S. F.
Pradere B.
Bcg
Bacillus Calmette–Guérin
Nmibc
bladder cancer
checkpoint inhibition therapy
nadofaragene firadenovec
non muscle invasive
oncolytic viruses
文献简介
原文链接
Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
2022 年 发布于
European Urology Focus
94 卷 第 5 期
Liu
C.
Q.
Sun J. X.
Xu J. Z.
Qian X. Y.
Hong S. Y.
Xu M. Y.
An Y.
Xia Q. D.
Hu J.
Wang S. G.
Cystectomy/methods
Humans
Quality of Life
*Urinary Bladder Neoplasms/surgery
*Urinary Diversion/methods
*Urinary Reservoirs
Continent
nursing
systematic review
urinary diversion
文献简介
原文链接
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis
2022 年 发布于
Bladder Cancer
2022 卷 第 5 期
Jazayeri S. B.
Dehghanbanadaki H.
Hosseini M.
Taghipour P.
Bazargani S.
Thomas D.
Feibus A.
Sarabchian E.
Bacchus M. W.
Di Valerio E. A.
Bandyk M.
Balaji K.
C.
Area Under Curve
*Carcinoma
Transitional Cell
Humans
In Situ Hybridization
Fluorescence
ROC Curve
Sensitivity and Specificity
*Urinary Bladder Neoplasms/pathology
Biomarker
Cytology
Diagnostic
Fluorescent in situ hybridization (FISH)
Meta-analysis
Upper urinary tract urothelial carcinoma (UTUC)
文献简介
原文链接
The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis
2022 年 发布于
Int J Urol
86 卷 第 1 期
Zhou W.
Liu J.
Mao D.
Hu
C.
Gao D.
Antibodies
Monoclonal
Humanized/*therapeutic use
*Carcinoma
Transitional Cell/drug therapy
Humans
Prognosis
Retrospective Studies
*Urinary Bladder Neoplasms/drug therapy
Metastatic urothelial carcinoma
Pembrolizumab
Prognostic factor
Janssen
and Pfizer. Takahiro Kimura is a paid consultant/advisor of Astellas
Bayer
Janssen and Sanofi. Shahrokh F. Shariat is a paid as follows: Honoraria:
Astellas
AstraZeneca
Bayer
BMS
Cepheid
Ferring
Ipsen
Janssen
Lilly
MSD
Olympus
Pfizer
Pierre Fabre
Richard Wolf
Roche
Sanochemia
Sanofi
Takeda
Urogen. Consulting or Advisory Role: Astellas
AstraZeneca
Bayer
BMS
Cepheid
Ferring
Ipsen
Janssen
Lilly
MSD
Olympus
Pfizer
Pierre Fabre
Richard Wolf
Roche
Sanochemia
Sanofi
Takeda
Urogen. Speakers Bureau: Astellas
Astra
Zeneca
Bayer
BMS
Cepheid
Ferring
Ipsen
Janssen
Lilly
MSD
Olympus
Pfizer
Pierre Fabre
Richard Wolf
Roche
Sanochemia
Sanofi
Takeda
Urogen
Movember Foundation. The other authors declare no conflicts of interest
associated with this manuscript.
文献简介
原文链接
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis
2022 年 发布于
PLoS One
104 卷 第 7 期
Peng L.
Meng
C.
Li J.
You
C.
Du Y.
Xiong W.
Xia Z.
Cao D.
Li Y.
Humans
Female
Male
Infant
*Urinary Bladder Neoplasms/diagnosis/therapy/pathology
*Carcinoma
Transitional Cell/pathology
Urinary Bladder/pathology
Neoplasm Staging
Cystoscopy
Cystectomy/methods
文献简介
原文链接
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
2022 年 发布于
African Journal of Urology
52 卷 第 6 期
Yanagisawa T.
Mori K.
Katayama S.
Mostafaei H.
Quhal F.
Laukhtina E.
Rajwa P.
Motlagh R. S.
Aydh A.
König F.
Grossmann N.
C.
Pradere B.
Miki J.
Kimura T.
Egawa S.
Shariat S. F.
*Carcinoma
Renal Cell/complications/epidemiology
*Carcinoma
Transitional Cell/complications/epidemiology
Cross-Sectional Studies
Hematuria/epidemiology/etiology
Humans
Incidence
*Kidney Neoplasms/complications/epidemiology
Male
Prospective Studies
Retrospective Studies
Risk Factors
*Urinary Bladder Neoplasms/complications/epidemiology
Age distribution
Cystoscopy
Haematuria
Kidney neoplasms
Radiotherapy
Sex
Smoking
Transitional cell carcinoma
Urinary bladder neoplasms
Urological neoplasms
文献简介
原文链接
A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation
2022 年 发布于
Urol Oncol
8 卷 第 5 期
Malde S.
Grover S.
Raj S.
Yuan
C.
Nair R.
Thurairaja R.
Khan M. S.
biomarker
bladder cancer
diagnosis
extracellular vesicle
miRNAs
pellet
sediment
supernatant
urine
文献简介
原文链接
首页
上一页
1
2
3
4
5
6
7
8
...
17
18
下一页
尾页
共359条,每页显示
20条
50条
100条
跳转至第
页
确定